UNIVERSITY OF NORTH CAROLINA HOSPITALS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1989-01-01

Employees: -

Market Cap: -

Website: http://www.unc.edu/interactive-tour/unc-hospitals/

Clinical Trials

Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: Pazopanib

First Posted Date: 2010-12-17

Last Posted Date: 2017-03-07

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 15

Registration Number: NCT01262820

Locations: 🇺🇸
North Carolina Cancer Hospital at U of North Carolina at CH, Chapel Hill, North Carolina, United States
🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

Trisenox® in Women With Metastatic Endometrial Cancer

Phase 2

Terminated

Conditions: Endometrial Carcinoma

Interventions: Drug: Arsenic trioxide

First Posted Date: 2010-08-18

Last Posted Date: 2017-06-14

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 3

Registration Number: NCT01184053

Locations: 🇺🇸
North Carolina Cancer Hosptial, UNC, Chapel Hill, North Carolina, United States

Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy

Phase 1

Completed

Conditions: Diarrhea
Neutropenia
Colorectal Cancer

Interventions: Drug: fluorouracil
Drug: leucovorin
Drug: oxaliplatin

First Posted Date: 2010-07-16

Last Posted Date: 2015-10-09

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 76

Registration Number: NCT01164215

Locations: 🇺🇸
Cancer Care of Western North Carolina, Asheville, North Carolina, United States
🇺🇸
Moses Cone Regional Cancer Center at Wesley Long Community Hospital, Greensboro, North Carolina, United States
🇺🇸
Marion L. Shepard Cancer Center, Washington, North Carolina, United States

and more 2 locations

Mammography Reminders for Encouraging Women to Undergo Regular Mammography Screenings for Breast Cancer

Completed

Conditions: Breast Cancer

First Posted Date: 2010-06-22

Last Posted Date: 2016-01-20

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 3547

Registration Number: NCT01148875

Biomarkers in Blood Samples From Older Breast Cancer Survivors

Completed

Conditions: Breast Cancer

Interventions: Genetic: gene expression analysis
Genetic: reverse transcriptase-polymerase chain reaction
Other: laboratory biomarker analysis
Other: medical chart review
Other: questionnaire administration

First Posted Date: 2010-06-07

Last Posted Date: 2014-02-27

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 246

Registration Number: NCT01138345

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States

Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Phase 1

Completed

Conditions: Liver Cancer

Interventions: Drug: doxorubicin hydrochloride
Drug: mitomycin C
Drug: sorafenib tosylate
Other: laboratory biomarker analysis
Other: pharmacological study

First Posted Date: 2009-11-11

Last Posted Date: 2018-01-05

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 11

Registration Number: NCT01011010

Locations: 🇺🇸
Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States
🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States

Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy

Phase 2

Withdrawn

Conditions: Lung Cancer

First Posted Date: 2009-10-20

Last Posted Date: 2012-03-06

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Registration Number: NCT00998101

Digital Breast Tomosynthesis Preference Study

Completed

Conditions: Breast Cancer

Interventions: Device: Digital Breast Tomosynthesis Exam

First Posted Date: 2008-10-20

Last Posted Date: 2017-03-06

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 51

Registration Number: NCT00776126

Locations: 🇺🇸
Breast Imaging Clinic; University of North Carolina Hospitals, Chapel Hill, North Carolina, United States

Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis

Phase 1

Terminated

Conditions: Liver Cancer

Interventions: Drug: sorafenib tosylate

First Posted Date: 2008-10-07

Last Posted Date: 2012-05-23

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 6

Registration Number: NCT00767468

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States

Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen

Phase 2

Completed

Conditions: Breast Cancer
Menopausal Symptoms

Interventions: Drug: tamoxifen citrate
Genetic: gene expression analysis
Other: pharmacogenomic studies
Other: questionnaire administration
Procedure: quality-of-life assessment

First Posted Date: 2008-10-02

Last Posted Date: 2017-08-01

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 501

Registration Number: NCT00764322

Locations: 🇺🇸
Moses Cone Regional Cancer Center at Wesley Long Community Hospital, Greensboro, North Carolina, United States
🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
🇺🇸
Blumenthal Cancer Center at Carolinas Medical Center, Charlotte, North Carolina, United States

and more 4 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy